UHCDS a-tDCS Combined With Therapeutic Exercise in Fibromyalgia Patients

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

November 15, 2023

Study Completion Date

November 30, 2023

Conditions
Fibromyalgia
Interventions
DEVICE

Real UHCDS a-tDCS

Real UHCDS a-tDCS (STARTSTIM® 8 stimulator, Neuroelectric Barcelona, Spain) for ten sessions (three sessions per week in weeks 1 and 2; and one session per week in weeks 3, 4, 5 and 6). UHCDS a-tDCS is a galvanic current applied by a cap for 20 minutes at an intensity of 2 milliamps.

DEVICE

Therapeutic exercise

The therapeutic exercise program will include aerobic exercise and muscle strengthening in the same days as UHCDS a-tDCS. The program will last 30-45 minutes.

DEVICE

Sham UHCDS a-tDCS

Sham UHCDS a-tDCS (STARSTIM® 8 stimulator, Neuroelectric Barcelona, Spain) for ten sessions (three sessions per week in weeks 1 and 2; and one session per week in weeks 3, 4, 5 and 6). Sham tDCS will be applied for the same time than real UHCDS a-tDCS.

Trial Locations (1)

45600

Hospital Nuestra Señora del Prado, Talavera de la Reina

All Listed Sponsors
lead

University of Castilla-La Mancha

OTHER